Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2 [Phase 1]
Phase 1 trial update showing safety and tolerability of AP 12009 (Trabedersen) administered intravenously in patients with advanced tumors o…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses [NA]
A completed clinical trial comparing two fine-needle biopsy needles for sampling solid pancreatic masses.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer [NA]
This clinical trial update reports on the safety and efficacy of irreversible electroporation for locally advanced pancreatic cancer in a Yo…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction [NA]
A completed clinical trial evaluating endoscopic ultrasound and endoscopic retrograde cholangiopancreatography for malignant distal biliary …
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: 22 G - 25 G SINS Trial for Pancreatic Masses [NA]
Clinical trial NCT02424838 (22G-25G SINS Trial for pancreatic masses) sponsored by AdventHealth has completed. The study concerns pancreatic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy [Phase 2]
The Phase 2 trial of luminespib (AUY922) in metastatic pancreatic cancer resistant to first-line chemotherapy was terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections [NA]
A completed clinical trial comparing wound vacuum dressing to standard closure for reducing surgical site infections, with results posted in…
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis [NA]
A trial comparing EUS-guided radiofrequency ablation versus EUS-guided celiac plexus neurolysis for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer [Phase 1]
Phase 1 clinical trial update for a margin-intense combination therapy in patients with potentially resectable pancreatic cancer; the trial …
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Acquisition of Portal Venous CTCs and Exosomes From Patients With Pancreatic Cancer by EUS
Clinical trial update on acquiring portal venous circulating tumor cells (CTCs) and exosomes from pancreatic cancer patients using endoscopi…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer [Phase 1]
A Phase 1 trial of a dendritic cell vaccine with chemotherapy for pancreatic cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study [NA]
This clinical trial update discusses the efficacy and safety of a novel endobiliary radiofrequency ablation catheter (ELRA) used to maintain…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel in combination with S-1 as induction therapy for locally advanced pancreatic cancer; current status …
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
This completed observational study assessed quality of life in patients with metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer [Phase 1, Phase 2]
This study evaluates neoadjuvant accelerated short-course radiation therapy with proton beam therapy plus capecitabine for resectable pancre…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial update of GTX (gemcitabine/taxotere/xeloda) with cisplatin in metastatic pancreatic cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Registry Study - Whipple at the Splenic Artery
A registry study evaluating the Whipple procedure at the splenic artery for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer. [EARLY_Phase 1]
This update notes the termination of an early-phase safety study evaluating an antibody for pancreatic cancer to determine the appropriate d…
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer [Phase 2]
This document notes a completed Phase 2 trial comparing nab-paclitaxel plus gemcitabine versus gemcitabine alone as first-line therapy for p…
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells [Phase 1, Phase 2]
Clinical trial update for an activated primary natural killer cell therapy showing intent to assess anti-tumor effects in multiple cancers i…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) [Phase 2]
Phase 2 trial update for nab-paclitaxel plus gemcitabine in locally advanced pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating ibritinib in combination with MEDI4736 in relapsed/refractory solid tumors completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 clinical trial evaluating masitinib in combination with gemcitabine for advanced/metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for tosedostat with capecitabine in metastatic pancreatic adenocarcinoma (Phase 1/2); study terminated with posted res…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas [Phase 2]
Phase 2 trial of FOLFIRINOX in metastatic high-grade gastroenteropancreatic neuroendocrine carcinomas was terminated; results posted in 2018…